Amino Acid Metabolism Practice Questions

Q: Which is the limiting amino acid in the Maple Syrup Urine Disease?

Tryptophan. ### Explanation **Correct Answer: B. Tryptophan** **Underlying Medical Concept:** Maple Syrup Urine Disease (MSUD) is caused by a deficiency in the **Branched-Chain Alpha-Keto Acid Dehydrogenase (BCKAD)** complex. This leads to the accumulation of Branched-Chain Amino Acids (BCAAs)—**Leucine, Isoleucine, and Valine**—and their corresponding alpha-keto acids in the blood and brain. The high concentration of Leucine outcompetes other Large Neutral Amino Acids (LNAAs) for transport across the blood-brain barrier via the **LAT1 transporter**. Since **Tryptophan** shares this same transporter, its entry into the brain is significantly inhibited. Consequently, Tryptophan becomes the **limiting amino acid** for protein synthesis and neurotransmitter production (like Serotonin) within the central nervous system, contributing to the neurotoxicity seen in MSUD. **Analysis of Incorrect Options:** * **A & C (Tyrosine and Phenylalanine):** While these are also Large Neutral Amino Acids that compete with Leucine for brain entry, Tryptophan is typically the least abundant and most severely restricted in the brain's amino acid pool during MSUD crises. * **D (None of the above):** Incorrect, as the competitive inhibition of amino acid transport is a well-documented biochemical feature of the disease. **High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Deficient:** BCKAD (requires Thiamine/B1, Lipoate, CoA, FAD, NAD). * **Diagnostic Marker:** Presence of **Alloisoleucine** in plasma (pathognomonic). * **Clinical Sign:** "Maple syrup" or "burnt sugar" odor in urine due to **alpha-keto-isovalerate**. * **Management:** Dietary restriction of BCAAs; some patients respond to high-dose **Thiamine (Vitamin B1)** supplementation.

Q: What is the precursor of norepinephrine?

Tyrosine. **Explanation:** The synthesis of catecholamines (Dopamine, Norepinephrine, and Epinephrine) follows a specific metabolic pathway starting from the amino acid **Tyrosine**. **1. Why Tyrosine is Correct:** Tyrosine is the direct precursor for the catecholamine pathway. The sequence of synthesis is as follows: * **Tyrosine** → (via Tyrosine Hydroxylase) → **L-DOPA** * L-DOPA → (via DOPA Decarboxylase) → **Dopamine** * Dopamine → (via Dopamine $\beta$-hydroxylase) → **Norepinephrine** * Norepinephrine → (via PNMT) → **Epinephrine** **2. Why the other options are incorrect:** * **Tryptophan:** This is the precursor for **Serotonin** (5-HT) and **Melatonin**, as well as Niacin (Vitamin B3). * **Methionine:** This is an essential sulfur-containing amino acid. Its primary role in this pathway is acting as a methyl donor (via S-adenosylmethionine or SAM) for the conversion of norepinephrine to epinephrine. * **Asparagine:** This is a non-essential amino acid involved in the urea cycle and glycoprotein synthesis, but it does not contribute to catecholamine production. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-Limiting Step:** **Tyrosine Hydroxylase** is the rate-limiting enzyme in catecholamine synthesis. * **Cofactor:** Tetrahydrobiopterin (**BH4**) is a required cofactor for Tyrosine Hydroxylase. * **PNMT Regulation:** The enzyme Phenylethanolamine N-methyltransferase (PNMT), which converts norepinephrine to epinephrine, is induced by **Glucocorticoids** (Cortisol). * **VMA:** Vanillylmandelic acid (VMA) is the end-stage urinary metabolite of both norepinephrine and epinephrine, used to diagnose Pheochromocytoma.

Q: All of the following are conditions associated with negative nitrogen balance, EXCEPT:

Convalescence. **Explanation:** Nitrogen balance is the measure of nitrogen intake (primarily through dietary protein) minus nitrogen excretion (via urine, feces, and sweat). **1. Why Convalescence is the Correct Answer:** **Convalescence** refers to the recovery phase following an illness or injury. During this period, the body is in a state of **Positive Nitrogen Balance**. The body actively repairs tissues and synthesizes new proteins to replace those lost during the acute phase of illness. Consequently, nitrogen intake exceeds excretion as the body retains nitrogen for anabolic processes. **2. Analysis of Incorrect Options (Negative Nitrogen Balance):** Negative nitrogen balance occurs when nitrogen excretion exceeds intake, typically due to increased protein catabolism or inadequate intake. * **Burns (A):** Severe tissue damage leads to massive protein breakdown and loss of nitrogen through exudates and hypermetabolism. * **Infection (C):** Acute infections trigger a stress response, releasing cortisol and inflammatory cytokines that promote skeletal muscle proteolysis to provide amino acids for gluconeogenesis and acute-phase protein synthesis. * **Malnutrition (D):** In conditions like Marasmus or Kwashiorkor, the lack of dietary protein forces the body to catabolize its own structural proteins for energy, leading to net nitrogen loss. **NEET-PG High-Yield Pearls:** * **Positive Nitrogen Balance:** Occurs during growth (childhood/adolescence), pregnancy, and convalescence (recovery). * **Negative Nitrogen Balance:** Occurs during starvation, uncontrolled diabetes, hyperthyroidism, cancer cachexia, and major trauma. * **Key Hormone:** Insulin promotes a positive nitrogen balance (anabolic), while Glucocorticoids (Cortisol) promote a negative nitrogen balance (catabolic).

Q: Which of the following groups of amino acids produce a common component of the TCA cycle?

Isoleucine, valine, methionine. **Explanation:** The correct answer is **C (Isoleucine, Valine, Methionine)**. These three amino acids, along with Threonine, are catabolized to form **Succinyl-CoA**, a key intermediate of the TCA cycle. **Why Option C is Correct:** The metabolic pathway for these amino acids involves their conversion into **Propionyl-CoA**, which is then carboxylated to Methylmalonyl-CoA and finally isomerized to **Succinyl-CoA**. This pathway is clinically significant as it requires Vitamin B12 (Cobalamin) and Biotin. A mnemonic often used is **VOMIT** (Valine, Odd-chain fatty acids, Methionine, Isoleucine, Threonine) to remember the precursors of Propionyl-CoA. **Analysis of Incorrect Options:** * **Option A:** Alanine produces Pyruvate; Leucine and Lysine are purely ketogenic (producing Acetyl-CoA/Acetoacetate); Isoleucine is both. They do not share a single common TCA component. * **Option B:** Serine and Glycine produce Pyruvate; Asparagine produces Oxaloacetate; Glutamate produces $\alpha$-ketoglutarate. They enter the cycle at different points. * **Option D:** Proline produces $\alpha$-ketoglutarate; Leucine produces Acetyl-CoA; Tryptophan produces Pyruvate and Acetyl-CoA. **High-Yield NEET-PG Pearls:** 1. **Purely Ketogenic Amino Acids:** Leucine and Lysine (the only two that cannot produce glucose). 2. **Propionic Acidemia:** Caused by a deficiency of Propionyl-CoA carboxylase (requires Biotin). 3. **Methylmalonic Aciduria:** Caused by a deficiency of Methylmalonyl-CoA mutase or Vitamin B12. This leads to the accumulation of methylmalonic acid, helping differentiate B12 deficiency from Folate deficiency. 4. **Glucogenic/Ketogenic:** Isoleucine, Phenylalanine, Tyrosine, and Tryptophan are both.

Q: Which of the following is a urea cycle enzyme?

Arginosuccinate synthetase. ### Explanation The **Urea Cycle (Ornithine Cycle)** is the primary pathway for detoxifying ammonia into urea in the liver. It consists of five main enzymatic steps, two occurring in the mitochondria and three in the cytosol. **Why Option C is Correct:** **Argininosuccinate synthetase** is the third enzyme of the urea cycle (the first cytosolic step). It catalyzes the condensation of **citrulline** and **aspartate** to form **argininosuccinate**. This step is crucial as it requires ATP and incorporates the second nitrogen atom (derived from aspartate) into the urea molecule. **Analysis of Incorrect Options:** * **A & B (Glutaminase & Asparaginase):** These are hydrolase enzymes involved in the deamination of glutamine and asparagine, respectively. While they release ammonia that may eventually enter the urea cycle, they are not part of the cycle itself. * **D (Ornithine transcarbamylase - OTC):** While OTC **is** a urea cycle enzyme (the second step), the question asks to identify "a" urea cycle enzyme among the choices. In many standardized formats, if multiple enzymes are listed, the question often focuses on the rate-limiting or specific regulatory steps. However, in this specific MCQ context, Argininosuccinate synthetase is the designated correct answer, often highlighted because it represents the transition to the cytosolic phase. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Carbamoyl Phosphate Synthetase I (CPS-I), which requires **N-acetylglutamate (NAG)** as an essential activator. * **Mnemonic for enzymes:** **C**ome **O**n **A**rginine **A**re **U**rea (**C**PS-I, **O**TC, **A**rgininosuccinate synthetase, **A**rgininosuccinate lyase, **A**rginase). * **Hyperammonemia Type II:** The most common urea cycle disorder, caused by a deficiency in **OTC** (X-linked recessive). * **Citrullinemia:** Caused by a deficiency in **Argininosuccinate synthetase**.

Q: What inborn error of metabolism is characterized by a swimming pool-like odor?

Hawkinsinuria. **Explanation:** **Hawkinsinuria** is a rare autosomal dominant metabolic disorder involving the metabolism of tyrosine. It is caused by a deficiency in the enzyme **4-hydroxyphenylpyruvate dioxygenase (4-HPPD)**. This defect leads to the accumulation of an intermediate metabolite called **Hawkinsin**. The characteristic clinical hallmark of this condition is a distinct **swimming pool-like odor** (chlorine-like) of the urine and sweat. Infants typically present with failure to thrive and metabolic acidosis when transitioning to high-protein diets (like breast milk or formula). **Analysis of Incorrect Options:** * **Tyrosinemia (Type I):** Characterized by a **boiled cabbage** or rancid butter odor due to the accumulation of succinylacetone. * **Phenylketonuria (PKU):** Characterized by a **mousy or musty odor** due to the accumulation of phenylacetic acid. * **Multiple Carboxylase Deficiency:** Often associated with a **tomcat urine** odor (similar to Isovaleric acidemia, which is "sweaty feet"). **NEET-PG High-Yield Pearls (Odors in Metabolic Disorders):** * **Maple Syrup Urine Disease (MSUD):** Burnt sugar/Maple syrup odor (Isoleucine). * **Isovaleric Acidemia / Glutaric Acidemia Type II:** Sweaty feet odor. * **Trimethylaminuria:** Fishy odor. * **Hypermethioninemia:** Boiled cabbage odor. * **Oasthouse Urine Disease:** Dried malt or hops odor. **Key Takeaway:** For NEET-PG, associate **Hawkinsinuria** specifically with the **"Swimming Pool/Chlorine"** odor and a defect in **Tyrosine** catabolism.

Q: What are the main sites for oxidative deamination?

Liver and kidney. **Explanation:** **Oxidative deamination** is the process by which an amino group is removed from an amino acid, resulting in the formation of a corresponding α-keto acid and ammonia. This is a crucial step in nitrogen metabolism, allowing the body to handle excess nitrogen. **Why Liver and Kidney are the correct sites:** The primary enzyme responsible for this process is **L-glutamate dehydrogenase (GDH)**. The **liver** is the central hub for nitrogen metabolism; it utilizes oxidative deamination to release ammonia from glutamate, which is then immediately converted into urea via the Urea Cycle for detoxification. The **kidneys** also possess high GDH activity; here, the released ammonia acts as a buffer by neutralizing metabolic acids in the tubular fluid (forming ammonium ions), which is essential for maintaining acid-base balance. **Analysis of Incorrect Options:** * **B, C, and D:** While organs like the pancreas, intestine, and lungs are metabolically active, they lack the high concentrations of GDH and the specialized metabolic machinery (like the Urea Cycle or significant renal ammoniagenesis) required to serve as "main sites" for systemic oxidative deamination. **High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Regulation:** L-glutamate dehydrogenase is unique because it can use either **NAD+ or NADP+** as a coenzyme. It is allosterically inhibited by ATP/GTP and activated by ADP/GDP (signaling low energy states). * **Clinical Correlation:** In liver failure, impaired oxidative deamination and urea synthesis lead to **hyperammonemia**, resulting in hepatic encephalopathy. * **Alternative Pathway:** Minor oxidative deamination also occurs via **L-amino acid oxidases** (FMN-dependent) and **D-amino acid oxidases** (FAD-dependent), primarily located in the peroxisomes of the liver and kidney.

Q: An infant presents with an eczematous rash, rhythmic rocking, microcephaly, and hypotonia. What is the likely diagnosis?

Phenylketonuria. **Explanation:** **Phenylketonuria (PKU)** is an autosomal recessive disorder caused by a deficiency of the enzyme **phenylalanine hydroxylase (PAH)** or its cofactor **tetrahydrobiopterin (BH4)**. This leads to the accumulation of phenylalanine and its metabolites (phenylpyruvate, phenyllactate) in the blood and brain. **Why Option A is correct:** The clinical presentation described is classic for untreated PKU: * **Eczematous rash:** A common dermatological manifestation due to melanin deficiency (phenylalanine inhibits tyrosinase). * **Neurological symptoms:** Rhythmic rocking, microcephaly, and hypotonia are signs of intellectual disability and CNS involvement caused by the neurotoxic effects of high phenylalanine levels. * **Mousy/Musty Odor:** (Though not mentioned here) is a hallmark sign due to phenylacetic acid in sweat and urine. **Why incorrect options are wrong:** * **Homocystinuria:** Characterized by a "marfanoid habitus," ectopia lentis (downward dislocation), and thromboembolic episodes. It does not typically present with an eczematous rash. * **Tyrosinosis (Tyrosinemia Type I):** Presents primarily with liver failure (cabbage-like odor), renal tubular dysfunction (Fanconi syndrome), and rickets. * **Autism:** While rhythmic rocking is a behavioral feature of autism, it does not explain the microcephaly, hypotonia, or the eczematous rash in an infant. **High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Defect:** Most commonly Phenylalanine Hydroxylase (PAH). * **Dietary Management:** Low phenylalanine diet; Tyrosine becomes an **essential amino acid** for these patients. * **Screening:** Guthrie Test (bacterial inhibition assay) or Tandem Mass Spectrometry. * **Maternal PKU:** If a mother has high Phe levels during pregnancy, the fetus may develop microcephaly, CHD, and IUGR, even if the fetus is heterozygous.

Q: Which of the following is not a ketogenic amino acid?

Histidine. ### Explanation The classification of amino acids as glucogenic, ketogenic, or both depends on the metabolic intermediates produced during their catabolism. **1. Why Histidine is the Correct Answer:** Histidine is a **purely glucogenic** amino acid. Its catabolism leads to the formation of **α-ketoglutarate**, an intermediate of the TCA cycle. Since it can be converted into glucose via gluconeogenesis but cannot be converted into ketone bodies (Acetyl-CoA or Acetoacetate), it is not ketogenic. **2. Analysis of Incorrect Options:** * **Leucine (Option A):** This is one of the two **purely ketogenic** amino acids. It is metabolized directly into Acetyl-CoA and Acetoacetate. * **Lysine (Option B):** Along with Leucine, Lysine is the second **purely ketogenic** amino acid. It cannot contribute to glucose synthesis. * **Tryptophan (Option C):** This is **both glucogenic and ketogenic** (amphibolic). Its breakdown yields pyruvate (glucogenic) and acetoacetyl-CoA (ketogenic). Other amino acids in this dual category include Isoleucine, Phenylalanine, and Tyrosine (Mnemonic: **PITTT** – Phenylalanine, Isoleucine, Tyrosine, Tryptophan, Threonine). **3. High-Yield Clinical Pearls for NEET-PG:** * **Purely Ketogenic:** Leucine and Lysine (The only two). * **Both (Glucogenic & Ketogenic):** Phenylalanine, Isoleucine, Tyrosine, Tryptophan, Threonine. * **Purely Glucogenic:** All remaining 13 amino acids (including Histidine, Arginine, and Valine). * **Clinical Correlation:** In patients with **Maple Syrup Urine Disease (MSUD)**, the metabolism of branched-chain amino acids (Leucine, Isoleucine, Valine) is impaired. Among these, Leucine is the most potent ketogenic amino acid and contributes significantly to the neurological symptoms seen in the condition.

Q: Which of the following amino acids is NOT secreted in cystinuria?

Histidine. **Explanation:** Cystinuria is an autosomal recessive disorder characterized by a defect in the high-affinity, sodium-independent transport system responsible for reabsorbing specific amino acids in the proximal convoluted tubule of the kidney and the small intestine. **Why Histidine is the correct answer:** The transport defect in cystinuria specifically involves **Cystine** and the three **dibasic amino acids**. Histidine, while often categorized as a basic amino acid due to its imidazole side chain, does not utilize this specific COAL transporter. Therefore, its renal reabsorption remains intact, and it is not excreted in the urine in patients with cystinuria. **Why the other options are incorrect:** The mnemonic **COAL** is used to remember the four amino acids that are NOT reabsorbed and thus excreted in excess: * **C:** **Cystine** (The least soluble, leading to hexagonal stone formation) * **O:** **Ornithine** (Option A) * **A:** **Arginine** (Option C) * **L:** **Lysine** (Option D) These three (O, A, L) are the dibasic amino acids that share the same defective transporter as cystine. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Patients present with recurrent **radiopaque** renal stones (calculi). * **Diagnosis:** The **Cyanide-Nitroprusside test** is the screening test of choice (turns purple/magenta). * **Microscopy:** Pathognomonic **hexagonal (6-sided) crystals** are seen in the urine sediment. * **Management:** Treatment focuses on increasing solubility via high fluid intake, urinary alkalinization (potassium citrate), and chelating agents like Penicillamine.

Question 1

Which is the limiting amino acid in the Maple Syrup Urine Disease?

Accepted Answer

Tryptophan

Answer

Tyrosine

Answer

Phenylalanine

Answer

None of the above

Question 2

What is the precursor of norepinephrine?

Accepted Answer

Tyrosine

Answer

Tryptophan

Answer

Methionine

Answer

Asparagine

Question 3

All of the following are conditions associated with negative nitrogen balance, EXCEPT:

Accepted Answer

Convalescence

Answer

Burns

Answer

Infection

Answer

Malnutrition

Question 4

Which of the following groups of amino acids produce a common component of the TCA cycle?

Accepted Answer

Isoleucine, valine, methionine

Answer

Alanine, isoleucine, leucine, lysine

Answer

Serine, asparagine, glycine, glutamate

Answer

Proline, leucine, tryptophan

Question 5

Which of the following is a urea cycle enzyme?

Accepted Answer

Arginosuccinate synthetase

Answer

Glutaminase

Answer

Asparaginase

Answer

Ornithine transcarbamylase

Question 6

What inborn error of metabolism is characterized by a swimming pool-like odor?

Accepted Answer

Hawkinsinuria

Answer

Tyrosinemia

Answer

Phenylketonuria

Answer

Multiple carboxylase deficiency

Question 7

What are the main sites for oxidative deamination?

Accepted Answer

Liver and kidney

Answer

Skin and pancreas

Answer

Intestine and mammary gland

Answer

Lung and spleen

Question 8

An infant presents with an eczematous rash, rhythmic rocking, microcephaly, and hypotonia. What is the likely diagnosis?

Accepted Answer

Phenylketonuria

Answer

Homocystinuria

Answer

Tyrosinosis

Answer

Autism

Question 9

Which of the following is not a ketogenic amino acid?

Accepted Answer

Histidine

Answer

Leucine

Answer

Lysine

Answer

Tryptophan

Question 10

Which of the following amino acids is NOT secreted in cystinuria?

Accepted Answer

Histidine

Answer

Ornithine

Answer

Arginine

Answer

Lysine

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?